MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Syndax Pharmaceuticals Total Inventories 2011-2026 | SNDX
Annual Total Inventories Syndax Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 366 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 366 K | 366 K | 366 K |
Quarterly Total Inventories Syndax Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 M | 17.7 M | 4.66 M | 366 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25 M | 366 K | 11.9 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.34 | -3.6 % | $ 357 M |  Britain |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K |  USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.57 | -3.38 % | $ 16.1 M | USA |
 |
Coherus BioSciences
CHRS
|
3.17 M | $ 1.6 | -4.19 % | $ 187 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 315.02 | -4.64 % | $ 41.3 B | USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.88 | -0.59 % | $ 4.8 M |  China |
 |
Cerus Corporation
CERS
|
56.1 M | $ 1.84 | -0.81 % | $ 351 M | USA |
 |
AbbVie
ABBV
|
4.95 B | $ 202.18 | -2.15 % | $ 358 B | USA |
 |
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.01 | -2.08 % | $ 429 M | USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 3.24 | -4.57 % | $ 968 M |  Canada |